World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000016092
Date of registration: 31/12/2014
Prospective Registration: Yes
Primary sponsor: National Hospital Organization Toneyama National Hospital
Public title: Analysis of the effects of animal fat free diet and aspirin for prostaglandins in patients with myotonic dystrophy
Scientific title: Analysis of the effects of animal fat free diet and aspirin for prostaglandins in patients with myotonic dystrophy - Animal fat free diet and aspirin in patients with myotonic dystrophy
Date of first enrolment: 2014/12/31
Target sample size: 10
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018689
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Not applicable
Countries of recruitment
Japan
Contacts
Name:     Yoshiko Tsuchie
Address:  Toneyama 5-1-1, Toyonaka, Osaka Japan
Telephone: 06-6853-2001
Email: chiken@toneyama.go.jp
Affiliation:  National Hospital Organization Toneyama National Hospital Clinical research center
Name:     Tsuyoshi Matsumura
Address:  Toneyama 5-1-1, Toyonaka, Osaka Japan
Telephone: 06-6853-2001
Email: tmatsumura-toneyama@umin.org
Affiliation:  National Hospital Organization Toneyama National Hospital Neurology
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: Patients with severe heart failure, hepatic failure, renal failure, hematological disorders, bleeding tendency or active illnesses (infection, allergic disorders). Patients taking anticoagulant or antiplatelet agents. Patients with active gastrointestinal ulcers. Patients in pregnancy Patients having history of any allergic responses for aspirin. Patients taking anti-inflammaotry or antiallergic agents.

Age minimum: Not applicable
Age maximum: Not applicable
Gender: Male and Female
Health Condition(s) or Problem(s) studied
myotonic dystrophy
Intervention(s)
1st stage (1w): animal fat free diet 2nd stage (1w): animal fat free diet and aspirin (330mg/day)
Primary Outcome(s)
Prostaglandins (PGD2, PGE2, etc.) and their metabolites
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
National Hospital Organization Toneyama National Hospital
Secondary Sponsor(s)
Graduate school of engineering Osaka University
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history